Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 11 2022 - 6:21PM
Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company
focused on the development and commercialization of transformative
and innovative infectious disease test kits, today announced that
on April 6, 2022, the Board of Directors of Lucira granted
inducement awards consisting of 20,825 restricted stock units
(“RSUs”) to three new employees under Lucira’s 2022 Inducement
Plan. The Board of Directors approved the awards as an inducement
material to the new employees’ employment in accordance with Nasdaq
Listing Rule 5635(c)(4).
The RSUs will vest over four years, with 25% of the underlying
shares vesting on the one year anniversary of the applicable
vesting commencement date and 1/16th of the underlying shares
vesting quarterly thereafter, subject to the new employees’
continued service relationship with Lucira through the applicable
vesting dates. The awards are subject to the terms and conditions
of Lucira’s 2022 Inducement Plan and the terms and conditions of an
applicable award agreement covering the grant.
About Lucira Health
Lucira is a medical technology company focused on the
development and commercialization of transformative and innovative
infectious disease test kits. Lucira’s testing platform produces
lab quality molecular testing in a single-use, consumer-friendly,
palm-size test kit powered by two AA batteries. Lucira designed its
test kits to provide accurate, reliable, and on-the-spot molecular
test results anywhere and at any time. The Lucira™ Check-It
COVID-19 Test Kit (OTC) and Lucira™ COVID-19 All-In-One Test Kit
(Rx) are designed to provide a clinically relevant COVID-19 result
within 30 minutes from sample collection. For more information,
visit www.lucirahealth.com.
Investor RelationsGreg
Chodaczekinvestorrelations@lucirahealth.com347-620-7010
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jul 2023 to Jul 2024